[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Phil Tennant, Precigen Chief Commercial Officer, reported the vesting of 25,000 performance stock units (PSUs) on 09/12/2025 that converted to common stock. The Form 4 shows these PSUs were part of an award originally granted August 28, 2024 and represent the second installment that vested after achievement of the applicable performance condition. Each PSU is payable in one share of the issuer's common stock or a cash equivalent. Following the reported transaction, Mr. Tennant beneficially owns 25,000 shares of Precigen common stock. The Form 4 was signed by attorney-in-fact Donald P. Lehr on 09/16/2025.

Positive

• 25,000 performance stock units vested and are recorded as converted to 25,000 shares of common stock
• PSUs were granted 08/28/2024 and vested upon achievement of the stated performance condition

Negative

• None.

Insights

Securities/Fiduciary Analyst

TL;DR: Officer received 25,000 PSUs that vested and converted to common stock or cash equivalent.

The Form 4 documents a non-derivative acquisition: the second installment of PSUs granted 08/28/2024 vested on 09/12/2025 and resulted in 25,000 shares of common stock beneficially owned by the reporting person, Phil Tennant, Chief Commercial Officer. The filing is routine disclosure under Section 16 showing compensation-related equity vesting tied to performance conditions. No transactions involving sales, option exercises, or cash payments are disclosed; the PSUs are described as payable in shares or cash equivalent.

Corporate Governance Expert

TL;DR: Governance filing confirms performance-based equity vesting for an executive, reported on Form 4.

The disclosure is concise and follows Form 4 requirements: it identifies the reporting person, relationship to the issuer (Officer, Chief Commercial Officer), the transaction date (09/12/2025), and the amount (25,000 PSUs resulting in 25,000 shares). The explanation clarifies these PSUs were part of an award from 08/28/2024 and vested upon satisfaction of performance conditions. The signature block shows filing via attorney-in-fact on 09/16/2025. No additional governance issues or irregularities are presented in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Tennant Phil

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units	(1)(2)	09/12/2025		A		25,000		(1)(2)	(1)(2)	Common Stock	25,000	$0	25,000	D

Explanation of Responses:

1. Represents the vesting of the second installment of performance stock units ("PSUs") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment.

2. Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value.

	/s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Phil Tennant report on Form 4 for PGEN?

The Form 4 reports the vesting of 25,000 performance stock units (PSUs) on 09/12/2025, resulting in 25,000 shares of common stock beneficially owned.

When were the PSUs originally granted to Phil Tennant?

The PSUs were originally granted on August 28, 2024 as stated in the Form 4 explanation.

How are the PSUs payable according to the filing?

Each PSU is payable in one share of common stock or a cash amount having an equivalent value.

What is Phil Tennant's role at Precigen as listed on the Form 4?

The filing lists Phil Tennant as an Officer, specifically the Chief Commercial Officer.

When was the Form 4 signed and filed?

The signature block shows the form was signed by attorney-in-fact Donald P. Lehr on 09/16/2025.